New findings from an oral health study conducted earlier this year by United Concordia Dental and Highmark Inc. show pharmacy costs can average $1,477 lower per year for diabetics who have gum disease and receive at least seven treatments or visits to treat the disease.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58161-highmark-united-concordia-dental-gum-disease-pharmacy-costs-diabetes
Ricola®, the leading manufacturer of soothing herb drops from Switzerland, has added a new product to its line of uniquely effective and delicious herb drops – Extra Strength for powerful cough relief.
Available in a “just-dripped-from-an icicle”-Glacier-Mint flavor, Extra Strength is cultivated from a blend of ten natural Swiss alpine herbs and a soothing syrup center that delivers powerful cough relief with natural menthol.
To view Multimedia News Release, go to http://www.multivu.com/mnr/63537-ricola-new-extra-strength-herb-cough-drops-menthol-syrup
The Asthma and Allergy Foundation of America (AAFA) and Teva Respiratory released results today from a new survey which showed that more than half (59 percent) of nasal allergy sufferers polled reported sleep issues as a result of their allergy symptoms, yet only 35 percent proactively treat their nasal allergy symptoms. Furthermore, nearly half of those surveyed (48 percent) said their nasal allergy symptoms, such as nasal congestion and sneezing, also interrupted their partner’s sleep.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60975-teva-respiratory-aafa-ditch-the-drip-misty-may-treanor-nasal-allergies
Vet in Athens Georgia http://TheCatandDogClinic.com
If you really love your pet you'll treat him/her like we do at The Cat and Dog Clinic in Athens Georgia. We love cats and dogs too and we take pride in giving them the very best care whether is boarding, vaccinations, emergencies... anything that requires loving care we're here for your family buddy.
More than 20 million Americans are currently affected by cataracts, and a new survey from AARP Media Sales and Alcon, the global leader in eye care, found that there are many questions and misperceptions among baby boomers about the condition, their options and how to treat it.
To view Multimedia News Release, go to http://www.multivu.com/mnr/63529-alcon-and-a-a-r-p-mark-world-sight-day-first-live-cataract-education-event
OptiNose US Inc. today announced results of a study testing delivery of the migraine medicine sumatriptan with a novel device using OptiNose breath powered Bi-Directional™ nasal technology. In a direct comparison of drug absorption, the study found that OptiNose's sumatriptan product sent 62% more drug into the blood in the critical first 15 minutes than Imitrex® nasal spray (AUC 0-15 = 1.69 ng*hr/mL and 1.04 ng*hr/mL, respectively). The OptiNose technology achieved this improved effect despite delivering 20% less drug into the nose (16mg) than the Imitrex® liquid nasal spray (20mg).
To view Multimedia News Release, go to http://www.multivu.com/players/English/57713-optinose-innovative-breath-powered-nasal-delivery-technology-delivers-drugs-to-treat-variety-of-medical-conditions
The number of gout patients is rising, with an estimated 8.3 million American adults diagnosed with gout—but only 10 percent of them are being properly treated, according to the Gout & Uric Acid Education Society. To heighten awareness and knowledge about gout and to lead to earlier diagnosis and treatment, the society has released two new comprehensive kits to educate patients and provide consistent information for medical professionals. The release of the Take a Stand on Gout Patient Education Kit and Medical Professional Information Kit coincides with Gout Awareness Day, an annual commemoration on May 22 to call attention to the growing incidence of gout and to enhance knowledge so as to improve patient outcomes. Both kits provide new, substantial information about gout from specialists, who treat gout patients every day.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61805-gout-uric-acid-education-society-take-a-stand-on-gout-new-information-kits
InSightec Ltd, the leader in magnetic resonance imaging (MRI)-guided Focused Ultrasound therapy, announced that the U.S. Food and Drug Administration (FDA) has approved ExAblate® MRI-guided focused ultrasound as a therapy to treat pain from bone metastases in patients who do not respond or cannot undergo radiation treatment for their pain. This is the second FDA approval for ExAblate, which has been used widely since it was approved in 2004 as a non-invasive, outpatient, therapy for uterine fibroids.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56632-insightec-fda-approves-exablate
A new treat from Cheryl Holt! In the “Reluctant Brides” trilogy, three spinsters suddenly learn that they’ve had dowries paid and marriages arranged for them. They grudgingly agree to marry men they’ve never met. Learn more about this trilogy and author at http://cherylholt.com/ Historical Romance
Does This World Famous Hair Regrowth Program Really Work Or Is It Just A Scam?
http://StopBalding.CureMyCondition.com This is not your average hair-loss product because it doesn\\\'t try to simply treat the symptoms... it works by getting to the true source of the problem and stopping it before it ever reaches your scalp.
Is This For Everybody?
No. Please only get this program if you are are willing to spend 3-5 minutes daily following the instructions contained in \\\
As the cold and flu season peaks, adults may take multiple over-the-counter (OTC) pain medicines to treat their pain and fever symptoms. Yet many are unaware of the serious liver or gastrointestinal damage that can result from the overdose or overuse of common OTC pain medicine ingredients. To help adults safely take these medicines, the American Gastroenterological Association (AGA) today launched Gut Check: Know Your Medicine, an education campaign focused on the safe use of OTC products. Central to the campaign is a unique flipbook-style video that highlights the importance of reading and following OTC medicine labels.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/65680-american-gastroenterological-aga-gut-check-know-your-medicine-otc-psa
Vioxx Settlement
This is an important announcement for consumers about the prescription drug Vioxx. Vioxx was a drug commonly used to treat pain and inflammation in adults with arthritis.
A settlement was reached with the manufacturer of Vioxx and will provide refunds to anyone who paid for the medication. Consumers are eligible to get $50 or more. Personal injury claims related to this drug are not included in this settlement.
The deadline to file a claim is approaching – claims must be filed by May 6, 2014.
Details are available at http://www.VioxxSettlement.com or by calling 1-866-439-6932.
